Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review

被引:2
作者
Zhang, Yanjie [1 ]
Pan, Juan [2 ]
Kang, Haixin [1 ]
Peng, Shuotao [1 ]
Tung, Tao-Hsin [3 ]
Shen, Bo [1 ]
机构
[1] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Clin Lab, Linhai, Peoples R China
[2] Zhejiang Univ, Taizhou Hosp, Dept Clin Lab, Linhai, Peoples R China
[3] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Evidence Based Med Ctr, Linhai, Peoples R China
关键词
multiple myeloma; renal impairment; progression-free survival; overall survival; prognosis; STEM-CELL TRANSPLANTATION; ACUTE KIDNEY INJURY; SWOG S0777; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; MANAGEMENT; OUTCOMES; IMPACT; INTENT;
D O I
10.1080/07853890.2024.2380301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMultiple myeloma is a malignant tumour of the blood in which abnormal proliferation of plasma cells leads to bone destruction, renal impairment, anaemia, and hypercalcaemia. Renal impairment caused by multiple myeloma is a common and serious condition; however, the prognosis of multiple myeloma at the time of diagnosis remains unclear.MethodWe conducted searches for literature in PubMed, Web of Science, Cochrane, Embase, CNKI, Wanfang, and VIP databases up to 30 April 2023. Progression-free survival and overall survival with and without renal impairment at the time of multiple myeloma diagnosis were compared, and prognostic indicators were analysed.ResultsSix studies were finally included. Among patients with multiple myeloma, 319 had renal impairment, and 1166 had no renal impairment. Compared to the control group, no significant difference was observed in overall or progression-free survival in patients with multiple myeloma complicated with renal impairment.ConclusionThe limited low-quality evidence available does not support an association between prognosis and multiple myeloma complicated by kidney injury.
引用
收藏
页数:9
相关论文
共 42 条
[11]   Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT) [J].
Durie, Brian G. M. ;
Hoering, Antje ;
Sexton, Rachael ;
Abidi, Muneer H. ;
Epstein, Joshua ;
Rajkumar, S. Vincent ;
Dispenzieri, Angela ;
Kahanic, Stephen P. ;
Thakuri, Mohan C. ;
Reu, Frederic J. ;
Reynolds, Christopher M. ;
Orlowski, Robert Z. ;
Barlogie, Bart .
BLOOD CANCER JOURNAL, 2020, 10 (05)
[12]   Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial [J].
Durie, Brian G. M. ;
Hoering, Antje ;
Abidi, Muneer H. ;
Rajkumar, S. Vincent ;
Epstein, Joshua ;
Kahanic, Stephen P. ;
Thakuri, Mohan ;
Reu, Frederic ;
Reynolds, Christopher M. ;
Sexton, Rachael ;
Orlowski, Robert Z. ;
Barlogie, Bart ;
Dispenzieri, Angela .
LANCET, 2017, 389 (10068) :519-527
[13]   A New Reality for Multiple Myeloma Renal Failure: US Data Report on Kidney Transplant Outcomes [J].
Dykes, Kaitlyn ;
Desale, Sameer ;
Javaid, Basit ;
Miatlovich, Krystsina ;
Kessler, Craig .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05) :E314-E320
[14]   Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology [J].
Fabbrini, P. ;
Finkel, K. ;
Gallieni, M. ;
Capasso, G. ;
Cavo, M. ;
Santoro, A. ;
Pasquali, S. .
JOURNAL OF NEPHROLOGY, 2016, 29 (06) :735-746
[15]   Acute kidney injury pathology and pathophysiology: a retrospective review [J].
Gaut, Joseph P. ;
Liapis, Helen .
CLINICAL KIDNEY JOURNAL, 2021, 14 (02) :526-536
[16]   Optimizing the Treatment of Patients With Multiple Myeloma and Renal Impairment [J].
Grzasko, Norbert ;
Morawska, Marta ;
Hus, Marek .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (04) :187-198
[17]   Supportive Care in Multiple Myeloma [J].
Guzdarl, Amy ;
Costello, Caitlin .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) :56-61
[18]   Kidney Transplant Outcomes of Patients With Multiple Myeloma [J].
Heybeli, Cihan ;
Bentall, Andrew J. ;
Alexander, Mariam Priya ;
Amer, Hatem ;
Buadi, Francis K. ;
Dispenzieri, Angela ;
Dingli, David ;
Gertz, Morie A. ;
Issa, Naim ;
Kapoor, Prashant ;
Kukla, Aleksandra ;
Kumar, Shaji ;
Lorenz, Elizabeth C. ;
Rajkumar, S. Vincent ;
Schinstock, Carrie A. ;
Leung, Nelson .
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04) :752-762
[19]  
Ikizler TA, 2020, AM J KIDNEY DIS, V76, pS11
[20]   Myeloma-related Kidney Disease [J].
Leung, Nelson ;
Nasr, Samih H. .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (01) :36-47